741 related articles for article (PubMed ID: 15893163)
21. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
22. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
[TBL] [Abstract][Full Text] [Related]
23. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
[TBL] [Abstract][Full Text] [Related]
24. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Bedi G; Redman J
Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
[TBL] [Abstract][Full Text] [Related]
25. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.
Murphy PN; Wareing M; Fisk JE; Montgomery C
Neuropsychobiology; 2009; 60(3-4):159-75. PubMed ID: 19893333
[TBL] [Abstract][Full Text] [Related]
26. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
[TBL] [Abstract][Full Text] [Related]
27. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of learning, memory, and executive function in new MDMA users.
Wagner D; Becker B; Koester P; Gouzoulis-Mayfrank E; Daumann J
Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704
[TBL] [Abstract][Full Text] [Related]
29. Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up.
Zakzanis KK; Campbell Z
Neurology; 2006 Mar; 66(5):740-1. PubMed ID: 16534114
[TBL] [Abstract][Full Text] [Related]
30. Mental disorders in current and former heavy ecstasy (MDMA) users.
Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
[TBL] [Abstract][Full Text] [Related]
31. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
Karlsen SN; Spigset O; Slørdal L
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
Hanson KL; Luciana M
J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
[TBL] [Abstract][Full Text] [Related]
33. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
Montoya AG; Sorrentino R; Lukas SE; Price BH
Harv Rev Psychiatry; 2002; 10(4):212-20. PubMed ID: 12119307
[TBL] [Abstract][Full Text] [Related]
34. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
Lyvers M
Drug Alcohol Rev; 2006 May; 25(3):269-76. PubMed ID: 16753651
[TBL] [Abstract][Full Text] [Related]
35. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Lamers CT; Bechara A; Rizzo M; Ramaekers JG
J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
[TBL] [Abstract][Full Text] [Related]
36. Everyday memory deficits in ecstasy-polydrug users.
Montgomery C; Fisk JE
J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
Back-Madruga C; Boone KB; Chang L; Grob CS; Lee A; Nations H; Poland RE
Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
[TBL] [Abstract][Full Text] [Related]
38. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
Dafters RI
Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723
[TBL] [Abstract][Full Text] [Related]
39. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
Curran HV; Travill RA
Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
[TBL] [Abstract][Full Text] [Related]
40. Verbal working memory deficits in current and previous users of MDMA.
Wareing M; Fisk JE; Murphy P; Montgomery C
Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
